Sotera Health Files 8-K: Regulation FD Disclosure
Ticker: SHC · Form: 8-K · Filed: Nov 20, 2024 · CIK: 1822479
| Field | Detail |
|---|---|
| Company | Sotera Health Co (SHC) |
| Form Type | 8-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financial-reporting
TL;DR
Sotera Health filed a routine 8-K on Nov 20, 2024, for disclosures.
AI Summary
Sotera Health Company filed an 8-K on November 20, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Sotera Health is adhering to its reporting obligations with the SEC, providing standard disclosures and financial information to the public.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for Regulation FD disclosures and financial exhibits, not indicating any new material risks or events.
Key Players & Entities
- Sotera Health Co (company) — Registrant
- November 20, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 473531161 (identifier) — IRS Number
- 9100 South Hills Blvd, Suite 300 (address) — Principal Executive Offices
- Broadview Heights, Ohio 44147 (address) — Principal Executive Offices Location
- 440-262-1410 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing for Sotera Health Co?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to provide Financial Statements and Exhibits as of November 20, 2024.
When was this 8-K filing submitted by Sotera Health Co?
This 8-K filing was submitted on November 20, 2024.
In which state is Sotera Health Company incorporated?
Sotera Health Company is incorporated in Delaware.
What is the address of Sotera Health Company's principal executive offices?
The address of Sotera Health Company's principal executive offices is 9100 South Hills Blvd, Suite 300, Broadview Heights, Ohio 44147.
Does this filing indicate any significant new financial events or material changes for Sotera Health?
This filing primarily serves as a standard disclosure and reporting of financial statements and exhibits; it does not detail any specific new financial events or material changes beyond these reporting requirements.
Filing Stats: 612 words · 2 min read · ~2 pages · Grade level 10.7 · Accepted 2024-11-20 09:16:00
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value per share SHC The Nasdaq
Filing Documents
- d874127d8k.htm (8-K) — 24KB
- d874127dex991.htm (EX-99.1) — 11KB
- g874127g12z27.jpg (GRAPHIC) — 7KB
- 0001193125-24-262222.txt ( ) — 168KB
- shc-20241120.xsd (EX-101.SCH) — 3KB
- shc-20241120_lab.xml (EX-101.LAB) — 18KB
- shc-20241120_pre.xml (EX-101.PRE) — 11KB
- d874127d8k_htm.xml (XML) — 4KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated November 20, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sotera Health Company (Registrant) Date: November 20, 2024 By: /s/ Jonathan M. Lyons Jonathan M. Lyons Senior Vice President and Chief Financial Officer